Search

everythinglearnresearchcommunity

for

Search:↓

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

The study created a new method to test drugs that affect hormone processing in skin.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Combining shikimic acid and Prunus mume extract may effectively treat acne naturally.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Nepenthes kampotiana extract can potentially prevent hair loss and could be an effective treatment for common baldness.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.